Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis.


OBJECTIVE Reactive amyloid A (AA) amyloidosis is a serious and life-threatening systemic complication of rheumatoid arthritis (RA). We evaluated the safety of therapy with anti-tumor necrosis factor and anti-interleukin 6 biologic agents in RA patients with reactive AA amyloidosis, together with prognosis and hemodialysis (HD)-free survival, in comparison… (More)
DOI: 10.3899/jrheum.111453

7 Figures and Tables


  • Presentations referencing similar topics